These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

919 related items for PubMed ID: 28668282

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW, Klaus LC, Karikari AA, Visanji NP, Brotchie JM, Lang AE, Volkmann J, Koprich JB.
    Acta Neuropathol Commun; 2017 Feb 01; 5(1):11. PubMed ID: 28143577
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M, Bar-On D, Calo' L, Anichtchik O, Iovino M, Xia J, Ryazanov S, Leonov A, Giese A, Dalley JW, Griesinger C, Ashery U, Spillantini MG.
    Acta Neuropathol; 2019 Oct 01; 138(4):575-595. PubMed ID: 31165254
    [Abstract] [Full Text] [Related]

  • 7. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
    Decressac M, Mattsson B, Lundblad M, Weikop P, Björklund A.
    Neurobiol Dis; 2012 Mar 01; 45(3):939-53. PubMed ID: 22182688
    [Abstract] [Full Text] [Related]

  • 8. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R, Cóppola-Segovia V, Miquel-Rio L, Alarcón-Aris D, Rodríguez-Aller R, Torres-López M, Paz V, Ruiz-Bronchal E, Campa L, Artigas F, Montefeltro A, Revilla R, Bortolozzi A.
    Int J Mol Sci; 2021 Mar 13; 22(6):. PubMed ID: 33805843
    [Abstract] [Full Text] [Related]

  • 9. Neuronal expression of familial Parkinson's disease A53T α-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice.
    Rothman SM, Griffioen KJ, Vranis N, Ladenheim B, Cong WN, Cadet JL, Haran J, Martin B, Mattson MP.
    J Parkinsons Dis; 2013 Mar 13; 3(2):215-29. PubMed ID: 23938351
    [Abstract] [Full Text] [Related]

  • 10. α-Synuclein Pathology and Reduced Neurogenesis in the Olfactory System Affect Olfaction in a Mouse Model of Parkinson's Disease.
    Martin-Lopez E, Vidyadhara DJ, Liberia T, Meller SJ, Harmon LE, Hsu RM, Spence N, Brennan B, Han K, Yücel B, Chandra SS, Greer CA.
    J Neurosci; 2023 Feb 08; 43(6):1051-1071. PubMed ID: 36596700
    [Abstract] [Full Text] [Related]

  • 11. α-Synuclein Spread from Olfactory Bulb Causes Hyposmia, Anxiety, and Memory Loss in BAC-SNCA Mice.
    Uemura N, Ueda J, Yoshihara T, Ikuno M, Uemura MT, Yamakado H, Asano M, Trojanowski JQ, Takahashi R.
    Mov Disord; 2021 Sep 08; 36(9):2036-2047. PubMed ID: 33547846
    [Abstract] [Full Text] [Related]

  • 12. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
    Frahm S, Melis V, Horsley D, Rickard JE, Riedel G, Fadda P, Scherma M, Harrington CR, Wischik CM, Theuring F, Schwab K.
    Behav Brain Res; 2018 Feb 26; 339():153-168. PubMed ID: 29180135
    [Abstract] [Full Text] [Related]

  • 13. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L, Eckermann K, Dambeck V, Fonseca-Ornelas L, Walle H, Lopes da Fonseca T, Koch JC, Becker S, Tönges L, Bähr M, Outeiro TF, Zweckstetter M, Lingor P.
    Acta Neuropathol Commun; 2016 Apr 22; 4():39. PubMed ID: 27101974
    [Abstract] [Full Text] [Related]

  • 14. Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant α-synuclein.
    Zhang S, Xiao Q, Le W.
    PLoS One; 2015 Apr 22; 10(3):e0119928. PubMed ID: 25799501
    [Abstract] [Full Text] [Related]

  • 15. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A, Rota D, Debetto P, Peroni D, Guidolin D, Negro A, Skaper SD, Giusti P.
    Neurobiol Dis; 2008 Apr 22; 30(1):8-18. PubMed ID: 18313315
    [Abstract] [Full Text] [Related]

  • 16. Non-motor parkinsonian pathology in aging A53T α-synuclein mice is associated with progressive synucleinopathy and altered enzymatic function.
    Farrell KF, Krishnamachari S, Villanueva E, Lou H, Alerte TN, Peet E, Drolet RE, Perez RG.
    J Neurochem; 2014 Feb 22; 128(4):536-46. PubMed ID: 24117685
    [Abstract] [Full Text] [Related]

  • 17. Environment-contact administration of rotenone: A new rodent model of Parkinson's disease.
    Liu Y, Sun JD, Song LK, Li J, Chu SF, Yuan YH, Chen NH.
    Behav Brain Res; 2015 Nov 01; 294():149-61. PubMed ID: 26239001
    [Abstract] [Full Text] [Related]

  • 18. IL-1β/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-Synuclein pathology in the olfactory bulb, substantia nigra and striatum.
    Niu H, Wang Q, Zhao W, Liu J, Wang D, Muhammad B, Liu X, Quan N, Zhang H, Zhang F, Wang Y, Li H, Yang R.
    Brain Pathol; 2020 Nov 01; 30(6):1102-1118. PubMed ID: 32678959
    [Abstract] [Full Text] [Related]

  • 19. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P.
    Proc Natl Acad Sci U S A; 2002 Aug 06; 99(16):10813-8. PubMed ID: 12122208
    [Abstract] [Full Text] [Related]

  • 20. Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease.
    Prediger RD, Aguiar AS, Rojas-Mayorquin AE, Figueiredo CP, Matheus FC, Ginestet L, Chevarin C, Bel ED, Mongeau R, Hamon M, Lanfumey L, Raisman-Vozari R.
    Neurotox Res; 2010 Feb 06; 17(2):114-29. PubMed ID: 19629612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.